Predictive Factors Affecting Axillary Lymph Node Metastasis in Breast Cancer

被引:0
作者
Benek, Suat [1 ]
Tatar, Cihad [2 ]
机构
[1] Silivri State Hosp, Clin Gen Surg, Istanbul, Turkey
[2] Istanbul Training & Res Hosp, Clin Gen Surg, Istanbul, Turkey
来源
HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI | 2019年 / 57卷 / 04期
关键词
Axillar; breast; cancer; lymph node; PROGNOSTIC-FACTORS; TUMOR SIZE; SURVIVAL; RECURRENCE; RECEPTOR; BIOPSY; NUMBER;
D O I
10.4274/haseki.galenos.2019.4983
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: The status of axillary lymph node metastasis (ALNM) at diagnosis has been considered as one of the most important prognostic factors for overall and disease-free survival in patients with breast cancer. Determination of breast cancer patients at risk for ALNM is important for treatment planning. The purpose of this study was to determine the factors that affect axillary lymph node involvement in breast cancer in addition to biological and pathological parameters to prevent unnecessary lymph node dissections. Methods: Immunohistochemical and pathologic features of 131 breast cancer patients, who underwent breast surgery, were investigated retrospectively. Results: ALNM was detected in 60% (n=79) of patients. In univariate analysis, histological grade, tumor size, lymphovascular invasion, perineural invasion, HER2 positivity and large intraductal component were found to be high risk factors for ALNM. In multivariate analysis, increased tumor size (T1; OR: 0.2, p<0.034) and presence of lymphovascular invasion (OR: 0.2, p<0.001) were found to be independent factors for ALNM. Conclusion: In our study, presence of lymphovascular invasion and increased tumor size were found to be independent predictive factors for axillary lymph node involvement. In univariate analysis, histological grade, tumor size, lymphovascular invasion, perineural invasion, HER2 positivity and large intraductal component were found to be high risk factors for ALNM. Patients carrying these factors may be included in the higher risk group for lymph node involvement. However, more data is needed to identify the factors that may help to decide for axillary lymph node dissection.
引用
收藏
页码:356 / 361
页数:6
相关论文
共 35 条
[1]   Lymphatic mapping and sentinel node biopsy in the patient with breast cancer [J].
Albertini, JJ ;
Lyman, GH ;
Cox, C ;
Yeatman, T ;
Balducci, L ;
Ku, NN ;
Shivers, S ;
Berman, C ;
Wells, K ;
Rapaport, D ;
Shons, A ;
Horton, J ;
Greenberg, H ;
Nicosia, S ;
Clark, R ;
Cantor, A ;
Reintgen, DS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (22) :1818-1822
[2]  
BERG JW, 1966, SURG GYNECOL OBSTETR, V122, P1311
[3]  
CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO
[4]  
2-H
[5]  
CLARK GM, 1988, SEMIN ONCOL, V15, P20
[6]  
CROWE JP, 1992, ARCH SURG-CHICAGO, V127, P910
[7]   ASSESSMENT OF AXILLARY LYMPH-NODE STATUS [J].
DAVIES, GC ;
MILLIS, RR ;
HAYWARD, JL .
ANNALS OF SURGERY, 1980, 192 (02) :148-151
[8]   Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients [J].
de Azambuja, E. ;
Cardoso, F. ;
de Castro, G., Jr. ;
Colozza, M. ;
Mano, M. S. ;
Durbecq, V. ;
Sotiriou, C. ;
Larsimont, D. ;
Piccart-Gebhart, M. J. ;
Paesmans, M. .
BRITISH JOURNAL OF CANCER, 2007, 96 (10) :1504-1513
[9]   Early and late morbidity associated with axillary levels I-III dissection in breast cancer [J].
Ernst, MF ;
Voogd, AC ;
Balder, W ;
Klinkenbijl, JHG ;
Roukema, JA .
JOURNAL OF SURGICAL ONCOLOGY, 2002, 79 (03) :151-155
[10]  
FISHER B, 1983, CANCER-AM CANCER SOC, V52, P1551, DOI 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO